Liu, Tao http://orcid.org/0000-0002-2001-8326
Chai, Shuang http://orcid.org/0000-0003-0212-662X
Li, Mingyang http://orcid.org/0000-0002-9379-3155
Chen, Xu
Xie, Yutao
Zhao, Zehui
Xie, Jingjing
Yu, Yunpeng http://orcid.org/0000-0002-4361-5828
Gao, Feng http://orcid.org/0000-0003-0938-5042
Zhu, Feng
Yang, Lihua http://orcid.org/0000-0003-2570-076X
Funding for this research was provided by:
National Natural Science Foundation of China (12174366)
Ministry of Education of the People's Republic of China (WK3450000005)
Natural Science Foundation of Anhui Province (2108085MC93)
Article History
Received: 29 March 2023
Accepted: 15 January 2024
First Online: 29 January 2024
Competing interests
: A patent application was submitted to the China National Intellectual Property Administration (patent applicant: University of Science and Technology of China; application number: 202311440399.0); Status of application: submitted; authors of this manuscript who are also listed as inventors of this patent: Lihua Yang, Shuang Chai, Tao Liu; specific contents of the manuscript covered in the patent application: the preparation of two sonosensitizing nanoparticles coated with lecithin membranes (namely, they are Ver-PLGA@Lecithin, and Ce6-PLGA@Lecithin) and the characterizations of their hydrodynamic diameters using dynamic light scattering (DLS), in vitro plate killing assays of Ver-PLGA@Lecithin and Ce6-PLGA@Lecithin nanoparticles against <i>H. pylori</i>, determination of the effect of US exposure-triggered killing of <i>H. pylori</i> by Ver-PLGA@Lecithin nanoparticles in gastric <i>H. pylori</i> infection-bearing mouse models with clinical triple therapy included for comparison, and determination of VacA removal by Ver-PLGA@Lecithin. The other authors of this manuscript (Mingyang Li, Xu Chen, Yutao Xie, Zehui Zhao, Jingjing Xie, Yunpeng Yu, Feng Gao and Feng Zhu) do not have competing interests.